Table of Contents Table of Contents
Previous Page  374 / 1631 Next Page
Information
Show Menu
Previous Page 374 / 1631 Next Page
Page Background

Summary of FDG PET in Early HL

• Using FDG PET it may be possible to identify a group of patients with an

excellent “early” outcome from chemotherapy alone

• EORTC H10 trial – failed to achieve this goal

• Favorable subgroup: 14.2% positive early PET scan

• UK NCRI RAPID results were achieved in the setting of

• Very conservative definition of PET negative 25.3 % PET positive

• Quality controlled PET image acquisition / Central review of PET images at

the Core Lab

• High quality reproducible PET required to deliver such results

• Longer follow-up is required to establish the impact of a PET negative

approach on 10 and 20 year survival and cause of death